Breast cancer patients given ‘new sense of hope’ after life-extending drug made available after U-turn
The National Institute for Health and Care Excellence (Nice) announced that it has reversed an initial decision to reject the drug for widespread use for the NHS in England
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.independent.co.uk — the content belongs to The Independent UK News.
